A-CAR028
/ AbelZeta Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 01, 2025
A Study of A-CAR028 Treatment in Subjects With Relapsed or Refractory Acute Myeloid Leukemia
(clinicaltrials.gov)
- P1 | N=20 | Recruiting | Sponsor: First Affiliated Hospital of Zhejiang University
New P1 trial • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology • CD33
1 to 1
Of
1
Go to page
1